ID
16058
Description
Documentation part: Investigation Product Information A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Keywords
Versions (1)
- 6/27/16 6/27/16 -
Uploaded on
June 27, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Investigation Product Information Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Investigation Product Information Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Description
Investigational Product
Description
Start date
Data type
date
Measurement units
- DDMONYYYY
Alias
- UMLS CUI [1]
- C0808070
Description
Start time
Data type
time
Measurement units
- hh:mm
Alias
- UMLS CUI [1]
- C1301880
Description
Stop Date
Data type
date
Measurement units
- DDMONYYYY
Alias
- UMLS CUI [1]
- C0806020
Description
Stop Time
Data type
time
Measurement units
- hh:mm
Alias
- UMLS CUI [1]
- C1522314
Description
Total number of applications
Data type
integer
Alias
- UMLS CUI [1,1]
- C0185125
- UMLS CUI [1,2]
- C0449788
Description
Investigational Product Use (IP USE)
Similar models
Investigation Product Information Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
C0449788 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0445107 (UMLS CUI [1,3])